Doberman pinschers present autoimmunity associated with functional autoantibodies: A model to study the autoimmune background of human dilated cardiomyopathy

被引:10
|
作者
Wess, Gerhard [1 ]
Wallukat, Gerd [2 ]
Fritscher, Anna [1 ]
Becker, Niels-Peter [2 ]
Wenzel, Katrin [2 ]
Mueller, Johannes [2 ]
Schimke, Ingolf [2 ]
机构
[1] Ludwig Maximilians Univ Munchen, Clin Small Anim Med, Munich, Germany
[2] Berlin Cures GmbH, Berlin, Germany
来源
PLOS ONE | 2019年 / 14卷 / 07期
关键词
MUSCARINIC RECEPTOR AUTOANTIBODIES; PROTEIN-COUPLED RECEPTORS; ANIMAL-MODELS; PATHOGENIC AUTOANTIBODIES; NEUTRALIZATION; EPITOPE; DEATH; SERUM; 1ST;
D O I
10.1371/journal.pone.0214263
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Autoimmunity associated with autoantibodies against the beta 1-adrenergic receptor (beta 1-AAB) is increasingly accepted as the driver of human dilated cardiomyopathy (DCM). Unfortunately, there is a lack of animal models to extend the knowledge about beta 1-AAB autoimmunity in DCM and to develop appropriate treatment strategies. Objectives To introduce an animal model, we investigated the beta 1-AAB associated autoimmunity in Doberman Pinscher (DP) with dilated cardiomyopathy, which has similarities to human DCM. Materials and methods Eighty-seven DP with cardiomyopathy in terms of pathological ECG and echocardiography (DoCM) and 31 dogs (at enrollment) without DoCM (controls) were analyzed for serum activity of beta 1-AAB with a bioassay that records the chronotropic response of spontaneously beating cultured neonatal rat cardiomyocytes to the DP's IgG. To locate the receptor binding site of beta 1-AAB and the autoantibody's sensitivity to inhibition, competing experiments with related blockers were performed with the bioassay. In controls that developed DoCM during follow-up, beta 1-AAB were analyzed during progress. Results Fifty-nine (67.8%) DoCM dogs and 19 (61.3%) controls were beta 1-AAB positive. Of the controls that developed DoCM, 8 were beta 1-AAB positive (p = 0.044 vs. dogs remaining in the control group); their beta 1-AAB activity increased with the cardiomyopathy progress (p< 0.02). To supplement DoCM group with the 9 animals which developed cardiomyopathy in the follow up, a more pronounced beta 1-AAB positivity became visible in the DoCM group (p = 0.066). Total and cardiac mortality were higher in beta 1-AAB positive DP (p = 0.002; p = 0037). The dogs' beta 1-AAB recognized a specific epitope on the second extracellular receptor and were sensitive to inhibition by drugs already successfully tested to inhibit the corresponding human autoantibody. Conclusions Doberman Pinschers presented beta 1-AAB associated autoimmunity, similar as in the pathogenesis of human DCM. Consequently, DP could compensate the lack of animal models for the investigation of beta 1-AAB autoimmunity in human DCM.
引用
收藏
页数:19
相关论文
共 12 条
  • [1] A Locus on Chromosome 5 Is Associated with Dilated Cardiomyopathy in Doberman Pinschers
    Mausberg, Theresa-Bernadette
    Wess, Gerhard
    Simak, Julia
    Keller, Lisa
    Droegemueller, Michaela
    Droegemueller, Cord
    Webster, Matthew T.
    Stephenson, Hannah
    Dukes-McEwan, Joanna
    Leeb, Tosso
    PLOS ONE, 2011, 6 (05):
  • [2] Efficacy of Pimobendan in the Prevention of Congestive Heart Failure or Sudden Death in Doberman Pinschers with Preclinical Dilated Cardiomyopathy (The PROTECT Study)
    Summerfield, N. J.
    Boswood, A.
    O'Grady, M. R.
    Gordon, S. G.
    Dukes-McEwan, J.
    Oyama, M. A.
    Smith, S.
    Patteson, M.
    French, A. T.
    Culshaw, G. J.
    Braz-Ruivo, L.
    Estrada, A.
    O'Sullivan, M. L.
    Loureiro, J.
    Willis, R.
    Watson, P.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2012, 26 (06) : 1337 - 1349
  • [3] A 16-bp deletion in the canine PDK4 gene is not associated with dilated cardiomyopathy in a European cohort of Doberman Pinschers
    Owczarek-Lipska, Marta
    Mausberg, Theresa-Bernadette
    Stephenson, Hannah
    Dukes-McEwan, Joanna
    Wess, Gerhard
    Leeb, Tosso
    ANIMAL GENETICS, 2013, 44 (02) : 239 - 239
  • [4] The Aptamer BC 007 for the Treatment of Dilated Cardiomyopathy Positive of Autoantibodies Directed Against the β1-Adrenergic Receptor: Evaluation of Safety, Efficacy and Survival in Doberman Pinschers
    Becker, Niels-Peter
    Werner, Sabine
    Wallukat, Gerd
    Wenzel, Katrin
    Mueller, Johannes
    Wess, Gerhard
    Schimke, Ingolf
    CIRCULATION RESEARCH, 2019, 125 (12) : E101 - E102
  • [5] In vitro evaluation of mitochondrial dysfunction and treatment with adeno-associated virus vector in fibroblasts from Doberman Pinschers with dilated cardiomyopathy and a pyruvate dehydrogenase kinase 4 mutation
    Sosa, Ivan
    Estrada, Amara H.
    Winter, Brandy D.
    Erger, Kirsten E.
    Conlon, Thomas J.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2016, 77 (02) : 156 - 161
  • [6] Study of the functional consequences of BAG3 molecular variants associated with human dilated cardiomyopathy
    Korniat, A.
    Dilanian, G.
    Duboscq-Bidot, L.
    Komajda, M.
    Villard, E.
    EUROPEAN HEART JOURNAL, 2013, 34 : 772 - 773
  • [8] Dilated cardiomyopathy in turkeys: An animal model for the study of human heart failure
    Genao, A
    Seth, K
    Schmidt, U
    Carles, M
    Gwathmey, JK
    LABORATORY ANIMAL SCIENCE, 1996, 46 (04): : 399 - 404
  • [9] Autoantibodies directed against the human β1-adrenergic receptor are associated with twofold increased mortality in dilated but not in ischemic cardiomyopathy
    Boivin, V
    Störk, S
    Horf, R
    Hein, L
    Angermann, CE
    Lohse, MJ
    Jahns, R
    HEART, 2004, 90 : A16 - A16
  • [10] Systemic autoimmunity induced by the TLR7/8 agonist Resiquimod causes myocarditis and dilated cardiomyopathy in a new mouse model of autoimmune heart disease
    Hasham, Muneer G.
    Baxan, Nicoleta
    Stuckey, Daniel J.
    Branca, Jane
    Perkins, Bryant
    Dent, Oliver
    Duffy, Ted
    Hameed, Tolani S.
    Stella, Sarah E.
    Bellahcene, Mohammed
    Schneider, Michael D.
    Harding, Sian E.
    Rosenthal, Nadia
    Sattler, Susanne
    DISEASE MODELS & MECHANISMS, 2017, 10 (03) : 259 - 270